Use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force

On 19 June 2018 the Senate referred the following matter to the Foreign Affairs, Defence and Trade References Committee for inquiry and report by 17 September 2018:

The use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.

Submissions to this inquiry close on 31 July 2018.

On 20 August 2018 the Senate agreed to extend the reporting date to 29 November 2018.

On 29 November 2018 the Senate agreed to extend the reporting date to 6 December 2018.

Committee Secretariat contact:

Foreign Affairs, Defence and Trade Committee
Department of the Senate
PO Box 6100
Parliament House
Canberra ACT 2600

Phone: +61 2 6277 3535
Fax: +61 2 6277 5818
fadt.sen@aph.gov.au

About this inquiry

Inquiry into the use of the Quinoline anti-malarial drugs Mefloquine and Tafenoquine in the Australian Defence Force.



Past Public Hearings

08 Nov 2018: Canberra
05 Nov 2018: Melbourne
15 Oct 2018: Canberra

more...

Inquiry Status

Report Tabled

Accessibility

If you require any special arrangements to enable you to participate in the Committee's inquiry, please contact the Committee Secretariat.

Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility